Literature DB >> 16532424

Diminished susceptibility to daptomycin accompanied by clinical failure in a patient with methicillin-resistant Staphylococcus aureus bacteremia.

David Hirschwerk1, Christine C Ginocchio, Maureen Bythrow, Susan Condon.   

Abstract

We cared for a patient with methicillin-resistant Staphylococcus aureus bacteremia who experienced clinical failure with daptomycin. The failure was accompanied by progressive elevation of the daptomycin minimum inhibitory concentration during treatment. DNA fingerprinting confirmed that the minimum inhibitory concentration elevation occurred within the same strain of methicillin-resistant Staphylococcus aureus. This observation provides important new information to clinicians who adopt this promising drug for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16532424     DOI： 10.1086/502688

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  13 in total

1.  Regulation of mprF by antisense RNA restores daptomycin susceptibility to daptomycin-resistant isolates of Staphylococcus aureus.

Authors:  Aileen Rubio; Mary Conrad; Robert J Haselbeck; Kedar G C; Vickie Brown-Driver; John Finn; Jared A Silverman
Journal:  Antimicrob Agents Chemother       Date:  2010-10-25       Impact factor: 5.191

2.  Prescribing trends with daptomycin (cubicin) for the treatment of gram-positive infections.

Authors:  Noreen H Chan Tompkins; Stephen J Harnicar
Journal:  P T       Date:  2008-05

3.  False daptomycin-nonsusceptible MIC results by Microscan panel PC 29 relative to Etest results for Staphylococcus aureus and enterococci.

Authors:  Elizabeth L Palavecino; Jacqueline M Burnell
Journal:  J Clin Microbiol       Date:  2012-10-17       Impact factor: 5.948

4.  Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.

Authors:  George Sakoulas; Arnold S Bayer; Joseph Pogliano; Brian T Tsuji; Soo-Jin Yang; Nagendra N Mishra; Victor Nizet; Michael R Yeaman; Pamela A Moise
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

Review 5.  Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient--a review of the literature.

Authors:  S J van Hal; D L Paterson; I B Gosbell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-12-30       Impact factor: 3.267

6.  Methicillin-resistant Staphylococcus aureus endocarditis and de novo development of daptomycin resistance during therapy.

Authors:  L Twele; E Moyen; K Zhang; B Dalton; D Church; J Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

7.  daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations.

Authors:  Warren E Rose; Steven N Leonard; George Sakoulas; Glenn W Kaatz; Marcus J Zervos; Anjly Sheth; Christopher F Carpenter; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2007-11-12       Impact factor: 5.191

8.  High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia.

Authors:  M Sharma; K Riederer; P Chase; R Khatib
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-23       Impact factor: 3.267

Review 9.  Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.

Authors:  Benjamin P Howden; John K Davies; Paul D R Johnson; Timothy P Stinear; M Lindsay Grayson
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

10.  Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.

Authors:  Yu-Tsung Huang; Cheng-Hsiang Hsiao; Chun-Hsing Liao; Chung-Wei Lee; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.